Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

SXTC stock hub

China SXT Pharmaceuticals, Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

SXTCis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

5.1M

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

SXTC

In the news

Latest news · SXTC

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROE-50.3

P25 -105.6P50 -46.5P75 -3.1

ROIC-6,457.2

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All SXTC market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

191

Groups with data

Currency

USD

Showing 191 of 191 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001723980
Company name	China SXT Pharmaceuticals, Inc.
Country	China
Country code	US
Cusip	G2161P165
Employees	75
Employees Change	-3%
Employees Change Percent	-3.85
Enterprise value	$-15M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Drug Manufacturers - Specialty & Generic
IPO Date	2019-01-04
Isin	VGG2161P1650
Last refreshed	2026-05-10
Market cap	$5.1M
Market cap category	Nano-Cap
Price	$1.73
Price currency	USD
Rev Per Employee	20,506.49x
Sector	Healthcare
Sic	2834
Symbol	SXTC
Website	https://www.sxtchina.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-173.33%
FCF yield	-53.6%
P/B ratio	0.07x
P/S ratio	3.33x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross margin	21.74%
Gross Profit	$334,395
Gross Profit Growth	-16.48%
Gross Profit Growth Q	-64.72%
Gross Profit Growth3 Y	-30.99%
Gross Profit Growth5 Y	-38.12%
Net Income	$-8.9M
Net Income Growth Years	0%
Pretax Margin	-576.72%
Profit Per Employee	$-118,265
ROA	-18.27
Roa5y	-7.45
ROCE	-41.1
ROE	-50.3
Roe5y	-27.88
ROIC	-6,457.2
Roic5y	-59.02

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-99.4%
Cagr3y	-93.37%
Cagr5y	-92.53%
EPS Growth Years	3
Revenue Growth	-15.42x
Revenue Growth Q	-24.46x
Revenue Growth Years	0x
Revenue Growth3 Y	-17.94x
Revenue Growth5 Y	-23.34x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.05
Assets	$26.4M
Cash	$21.3M
Current Assets	$26M
Current Liabilities	$6M
Debt	$1.2M
Debt Equity	$0.06
Equity	$20.2M
Interest Coverage	-12.25
Liabilities	$6.1M
Long Term Assets	$310,889
Long Term Liabilities	$158,262
Net Cash	$20.1M
Net Cash By Market Cap	$393
Net Cash Growth	154.7%
Net Debt Equity	$-0.99
Tangible Book Value	$20.2M
Tangible Book Value Per Share	$26.15
WACC	20.72

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	4.37
Inventory Turnover	0.7
Net Working Capital	$-181,095
Quick ratio	4.04
Working Capital	$20.1M
Working Capital Turnover	$0.13

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-99.39%
200-day SMA	135.7
3Y total return	-99.97%
50-day SMA	1.91
50-day SMA vs 200-day SMA	50under200
5Y total return	-100%
All Time High	56,035,517.2
All Time High Change	-100%
All Time High Date	2019-01-10
All Time Low	1.25
All Time Low Change	38.4%
All Time Low Date	2026-03-30
ATR	0.37
Beta	1.96
Beta1y	0.31
Beta2y	0.95
Ch YTD	-99.28
High	1.76
High52	1,047
High52 Date	2026-01-08
High52ch	-99.83%
Low	1.67
Low52	1.25
Low52 Date	2026-03-30
Low52ch	38.4%
Ma50ch	-9.52%
Premarket Change Percent	11.45
Premarket Price	$1.85
Premarket Volume	507
Price vs 200-day SMA	-98.73%
RSI	31.61
RSI Monthly	16.91
RSI Weekly	26.37
Sharpe ratio	-1.55x
Sortino ratio	-1.9
Tr YTD	-99.28
Tr1m	-16.43%
Tr1w	-16.43%
Tr3m	-42.33%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	$-8.4M
Operating margin	-544.9

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	2,684,758%
Float Percent	90.76%
Net Borrowing	-1,338,806
Shares Insiders	9.24%
Shares Institutions	0.09%
Shares Out	2,958,077
Short Ratio	0.1
Short Shares	0.96

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-8.4M
Average Volume	22,809.7x
Bv Per Share	26.16
CAPEX	$-2,023
Ch1m	-16.43
Ch1w	-16.43
Ch1y	-99.39
Ch3m	-42.33
Ch3y	-99.97
Ch5y	-100
Ch6m	-99.16
Change	4.22%
Change From Open	3.35
Close	1.66
Days Gap	0.84
Depreciation Amortization	45,858
Dollar Volume	16,785.3
Earnings Date	2019-08-19
Earnings Time	bmo
EBIT	$-8.4M
EBITDA	$-8.3M
EPS	$-22.46
F Score	3
FCF	$-2.7M
FCF EV Yield	18.3x
FCF Per Share	$-0.93
Financing CF	6,533,066
Fiscal Year End	March
Founded	2,005
Investing CF	-901,587
Ipr	-56.75
Iprfo	-100
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2019-08-19
Last Report Date	2025-09-30
Last Split Date	2026-02-03
Last Split Type	Reverse
Last10k Filing Date	2025-07-31
Ma150	100
Ma150ch	-98.27%
Ma20	2
Ma20ch	-13.37%
Net CF	2,684,739
Open	1.67
Optionable	No
Position In Range	64.84
Post Close	1.73
Postmarket Change Percent	-1.84
Postmarket Price	$1.7
Ppne	302,357
Pre Close	1.66
Price Date	2026-05-08
Ptbv Ratio	0.25
Relative Volume	0.43x
Revenue	1,537,987x
SBC By Revenue	368.97x
Share Based Comp	5,674,664
Tr6m	-99.16%
Volume	9,702.5
Z Score	4.61

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does SXTC pay a dividend?

Capital-return profile for this ticker.

Performance

SXTC stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns SXTC?

Insider, institutional, and short-interest positioning.

Institutional ownership

+0.1%

Float: +90.8% of shares outstanding

Insider ownership

+9.2%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

SXTC momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

31.6

Neutral momentum band

Price vs 200-day MA

-98.7%

50/200-day relationship not available

Beta (5Y)

1.96

More volatile than the market

Sharpe ratio

-1.55

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About SXTC

Hub-level FAQ points readers to the deeper analysis pages.

What is the current SXTC stock rating?

China SXT Pharmaceuticals, Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full SXTC analysis?

The full report lives at /stocks/SXTC/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for SXTC?

The latest report frames SXTC around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the SXTC page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.